ATE261987T1 - Cycloalkyl inhibitoren der protein- farnesyltransferase - Google Patents

Cycloalkyl inhibitoren der protein- farnesyltransferase

Info

Publication number
ATE261987T1
ATE261987T1 AT97954575T AT97954575T ATE261987T1 AT E261987 T1 ATE261987 T1 AT E261987T1 AT 97954575 T AT97954575 T AT 97954575T AT 97954575 T AT97954575 T AT 97954575T AT E261987 T1 ATE261987 T1 AT E261987T1
Authority
AT
Austria
Prior art keywords
farnesyl transferase
protein farnesyl
inhibitors
cycloalkyl
cycloalkyl inhibitors
Prior art date
Application number
AT97954575T
Other languages
English (en)
Inventor
Annette Marian Doherty
James Stanley Kaltenbronn
Daniele M Leonard
Namara Dennis Joseph Mc
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE261987T1 publication Critical patent/ATE261987T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97954575T 1996-12-17 1997-12-16 Cycloalkyl inhibitoren der protein- farnesyltransferase ATE261987T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3366196P 1996-12-17 1996-12-17
US5683197P 1997-08-22 1997-08-22
PCT/US1997/023280 WO1998027109A1 (en) 1996-12-17 1997-12-16 Cycloalkyl inhibitors of protein farnesyltransferase

Publications (1)

Publication Number Publication Date
ATE261987T1 true ATE261987T1 (de) 2004-04-15

Family

ID=26709973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97954575T ATE261987T1 (de) 1996-12-17 1997-12-16 Cycloalkyl inhibitoren der protein- farnesyltransferase

Country Status (21)

Country Link
US (1) US6281194B1 (de)
EP (1) EP0951471B1 (de)
JP (1) JP2001506265A (de)
KR (1) KR20000057601A (de)
AT (1) ATE261987T1 (de)
AU (1) AU721786C (de)
BR (1) BR9713744A (de)
CA (1) CA2264207A1 (de)
CO (1) CO4920227A1 (de)
DE (1) DE69728165T2 (de)
DK (1) DK0951471T3 (de)
ES (1) ES2216189T3 (de)
HR (1) HRP970693B1 (de)
ID (1) ID19142A (de)
IL (1) IL128546A0 (de)
NO (1) NO992933L (de)
NZ (1) NZ334702A (de)
PE (1) PE46999A1 (de)
PT (1) PT951471E (de)
TW (1) TW552259B (de)
WO (1) WO1998027109A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998027109A1 (en) 1996-12-17 1998-06-25 Warner-Lambert Company Cycloalkyl inhibitors of protein farnesyltransferase
BR9909961A (pt) * 1998-04-27 2000-12-26 Warner Lambert Co Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
AU2007229363B2 (en) * 2001-08-24 2009-06-04 University Of South Florida Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment
ATE530184T1 (de) * 2001-08-24 2011-11-15 Univ Yale Piperazinon-verbindungen als tumor- und krebsbekämpfende wirkstoffe
US20070275956A1 (en) * 2003-10-14 2007-11-29 Lohray Braj B Novel Heterocyclic Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2170766A1 (en) * 1993-11-05 1995-05-11 Gary Louis Bolton Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
WO1998027109A1 (en) 1996-12-17 1998-06-25 Warner-Lambert Company Cycloalkyl inhibitors of protein farnesyltransferase

Also Published As

Publication number Publication date
EP0951471A1 (de) 1999-10-27
BR9713744A (pt) 2000-03-21
PE46999A1 (es) 1999-05-20
PT951471E (pt) 2004-08-31
KR20000057601A (ko) 2000-09-25
NZ334702A (en) 2000-11-24
DK0951471T3 (da) 2004-07-19
TW552259B (en) 2003-09-11
JP2001506265A (ja) 2001-05-15
NO992933D0 (no) 1999-06-16
IL128546A0 (en) 2000-01-31
CO4920227A1 (es) 2000-05-29
AU721786C (en) 2001-08-02
CA2264207A1 (en) 1998-06-25
WO1998027109A1 (en) 1998-06-25
AU721786B2 (en) 2000-07-13
HRP970693B1 (en) 2002-06-30
DE69728165D1 (de) 2004-04-22
NO992933L (no) 1999-06-16
ID19142A (id) 1998-06-18
HRP970693A2 (en) 1998-10-31
DE69728165T2 (de) 2005-01-20
ES2216189T3 (es) 2004-10-16
EP0951471B1 (de) 2004-03-17
US6281194B1 (en) 2001-08-28
AU5899098A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE200085T1 (de) Histidine und homohistidine derivate zur verwendung als protein farnesyltransferase hemmstoffe
DE69427127D1 (de) Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
ES2173887T3 (es) Nuevos usos farmaceuticos de las enzimas de krill.
ATE261987T1 (de) Cycloalkyl inhibitoren der protein- farnesyltransferase
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
AU2821000A (en) Matrix protein compositions for induction of apoptosis
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.
ECSP972339A (es) Inhibidores de cicloalquilo de la farnesil transferasa de las proteinas
AU2990300A (en) Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951471

Country of ref document: EP

REN Ceased due to non-payment of the annual fee